Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CTI BioPharma Corp.
DescriptionSynthetic DNA minor groove binding agent
Molecular Target DNA
Mechanism of ActionMinor groove binder
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationBreast cancer
Indication DetailsTreat metastatic triple-negative breast cancer (TNBC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today